Which of the following agents is recommended as first line drug for treatment of gastrointestinal stromal tumors (GIST)?
Imatinib is drug of choice for GIST. Imatinib resistant cases can be treated with sunitinib. Tumors resistant to both imatinib and sunitinib are treated with regorafenib.
Sorafenib
Geftinib
Imatinib
Erlotinib
Targeted Anticancer Drugs and Immunosuppressants